By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cerecor Inc. 

2400 Boston Street
Suite 324
Baltimore  Maryland  21224  U.S.A.
Phone: 410-522-8707 Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Cerecor
Employees:
Symbol: CERC
 




Segment
Start Up





Company News
Cerecor (CERC) Plunges After Midstage Trial Failure of Nicotine Withdrawal Drug 12/5/2016 7:28:43 AM
Cerecor (CERC) Tanks as Lead Depression Drug Flops in Mid-Stage Study 11/30/2016 5:44:20 AM
Discovery Of Cerecor Drug Candidate CERC-611 (LY3130481) Published In Nature Medicine 11/9/2016 9:54:16 AM
Alkermes (ALKS)' Success Puts the Spotlight on Cerecor, Eli Lilly (LLY)'s 2015 Deal 10/21/2016 7:24:12 AM
Cerecor Inc. To Present At The 15th Annual BIO Investor Forum In San Francisco On October 18th, 2016 10/10/2016 9:28:11 AM
Cerecor Inc. To Present At The 15th Annual BIO Investor Forum In San Francisco On October 18th, 2016 10/10/2016 9:18:32 AM
Cerecor Inc. Announces Acquisition Of TARP-G8-AMPA Receptor Antagonist (CERC-611) From Eli Lilly (LLY) 9/26/2016 11:01:46 AM
Cerecor Inc. Announces Completion Of Enrollment In Phase II Clinical Trial With CERC-301 As An Oral, Adjunctive Treatment Of Major Depressive Disorder 9/21/2016 11:08:42 AM
Cerecor Inc. Enters Into A $15 Million Common Stock Purchase Agreement With Aspire Capital Fund 9/12/2016 10:27:22 AM
Cerecor Inc. Announces Last Patient Enrolled In Phase II Clinical Trial With CERC-501 For Smoking Cessation 9/6/2016 11:02:20 AM
123456
//-->